Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Injury ; 49(5): 927-932, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29602488

RESUMO

BACKGROUND: Arterial and central venous femoral catheters (fAC-CVC) use during the initial management of severe trauma patients is not a standard technique in most trauma centers. Arguments in favor of their use are: continuous monitoring of blood pressure, safe drug administration, easy blood sampling and potentially large bore venous access. The lack of evidence makes the practice heterogeneous. The aim of the present study was to describe the use and complications of fAC-CVC in the trauma bay in two centers where they are routinely used. METHODS: This was a retrospective analysis of routine fAC-CVC use from two French trauma centers. All patients admitted directly to the trauma resuscitation room were included. Demographic, clinical and biological data were collected from the scene to discharge to describe the use of catheters during initial trauma management including infectious, mechanical and thrombotic complications. RESULTS: 243 pairs of femoral catheters were inserted among 692 patients admitted in both trauma centers. Femoral AC-CVC use was more frequent in critically ill patients with higher ISS 26 [17; 41] vs 13 [8; 24], p < 0.001(median [quartile 1-3]), severe traumatic brain injury (AIS head 1[0-4] vs 0[0-3], p < 0.001), lower systolic blood pressure, 92 (37) vs 113 (28) mmHg, p < 0.001 mean (standard deviation), lower haemoglobin on arrival, 10.9 (3) vs 13.3 (2.1) g/dL (p < 0.001), and higher blood lactate concentration, 4.0 (3.9) vs 2.1 (1.8) mmol/L (p < 0.001). In patients with fAC-CVC use time in the trauma room was longer, 46 [40;60] vs 30 [20;40] minutes (p < 0.05). In total 52 colonizations and 3 bloodstream infections were noted in 1000 catheter days. An incidence of 12% of mechanical complications and of 42% deep venous thromboses were observed. Of the latter none was associated with confirmed pulmonary embolism. CONCLUSION: Femoral AC-CVC appeared to be deployed more often in critically ill patients, presenting with shock and/or traumatic brain injury in particular. The observed rate of complications in this sample seems to be low compared to reported rates.


Assuntos
Cateterismo Venoso Central/métodos , Cateteres Venosos Centrais , Ressuscitação , Centros de Traumatologia , Ferimentos e Lesões/terapia , Adulto , Infecções Relacionadas a Cateter/epidemiologia , Cateteres Venosos Centrais/efeitos adversos , Estado Terminal , Feminino , Artéria Femoral , Humanos , Masculino , Pessoa de Meia-Idade , Ressuscitação/métodos , Estudos Retrospectivos , Resultado do Tratamento , Trombose Venosa/epidemiologia , Ferimentos e Lesões/fisiopatologia , Adulto Jovem
2.
Rev Med Interne ; 27(8): 595-9, 2006 Aug.
Artigo em Francês | MEDLINE | ID: mdl-16822596

RESUMO

OBJECTIVE: The clinical presentation of acute schistosomiasis in travellers differs from those observed with chronic schistosomiasis in people from endemic areas. The objective of this study is to describe the main clinical and biological characteristics of the acute schistosomiasis in French travellers. METHODS: Retrospective study conducted in 42 hospital laboratories of parasitology in France, based on a questionnaire filled out for each case of schistosomiasis diagnosed in subjects non-originating from an endemic country and returning from of a stay in Africa, between 2000 and 2004. RESULTS: Seventy-seven cases of acute schistosomiasis diagnosed between 2000 and 2004 were reported by 15 of the 33 laboratories having taken part in the study. The patients were 26 years old on average and 60% were contaminated in West Africa. Seventy patients (91%) presented at least one symptom at the moment of the diagnosis, but only 44 (57%) presented sufficiently intense symptoms to justify a medical consultation spontaneously. The most frequently reported clinical signs were fever (44%), diarrhoea (40%), pruritus (25%), cough (21%) and hematuria (20%). Hypereosinophilia (82%), elevated liver enzymes and positive serology were respectively reported in 82, 23 and 90% of the cases. Ova were found in the urines or the stool in 60% of the cases. Eleven patients were hospitalized. DISCUSSION: Acute schistosomiasis must be evoked in patients returning from endemic country and presenting with non-specific symptoms; including patients whose bathes in contaminated water was limited to a short contact of the feet in a river. The high frequency of the asymptomatic or paucisymptomatic forms exposes the infected people to a delayed diagnosis and therefore to an evolution towards the chronic form of schistosomiasis. The increase in tourism towards the endemic areas could be accompanied by an increase in the frequency of the schistosomiasis, and encourages setting-up an active monitoring of acute schistosomiasis.


Assuntos
Esquistossomose/epidemiologia , Viagem , Doença Aguda , Adolescente , Adulto , África Ocidental , Criança , Feminino , França/epidemiologia , Hospitalização , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Esquistossomose/diagnóstico , Inquéritos e Questionários
6.
Br J Anaesth ; 54(6): 643-5, 1982 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-6123338

RESUMO

Org NC 45 60-80 microgram kg-1 was administered to 20 pregnant women undergoing general anaesthesia for Caesarean section. Org NC 45 plasma concentrations were measured fluorimetrically in samples of maternal, venous and arterial cord blood obtained at delivery. The venous cord to maternal concentration ratio averaged 11% and was not influenced by the interval between induction and delivery. The venous cord plasma concentration averaged 40 ng ml-1. The arterial cord concentration was less than the venous cord concentration in every instance and was undetectable in four patients. It is concluded that Org NC 45 crosses the human placental barrier to a very limited extent and that its use during anaesthesia for Caesarean section is safe for the newborn.


Assuntos
Cesárea , Troca Materno-Fetal/efeitos dos fármacos , Bloqueadores Neuromusculares/sangue , Pancurônio/análogos & derivados , Índice de Apgar , Feminino , Sangue Fetal/metabolismo , Humanos , Recém-Nascido , Pancurônio/sangue , Pancurônio/farmacologia , Gravidez , Brometo de Vecurônio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA